Peptide questions · Abaloparatide

How long does abaloparatide take to work?

Reviewed Evidence: EstablishedPublished by PepVault

Abaloparatide’s onset is 1 month (bone formation markers), its peak effect comes at 12–18 months (BMD, fracture risk), and its typical duration is up to 24 months, by the library’s timeline (backed by clinical trial data).

The timeline’s basis: FDA Tymlos label (DailyMed, effective August 2026); ACTIVE (Miller 2016). Approved for osteoporosis at high fracture risk in postmenopausal women and men.

Abaloparatide week by week

The library places four of its research notes on abaloparatide on the days they cover, from day 1 to day 730: 4 on randomized trials.

Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.

The abaloparatide notes by day
WhenThe noteEvidence
Days 1–14 (weeks 1–2)The first shots, sitting downRandomized trial
Days 14–60 (weeks 2–9)Redness where the shot goes inRandomized trial
Days 60–365 (weeks 9–53)New bone, built in the backgroundRandomized trial
Days 365–730 (weeks 53–105)Fewer fractures, then the 2-year lineRandomized trial
A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Track abaloparatide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The abaloparatide timeline’s milestones

The library’s timeline for abaloparatide marks 5 points from week 1 to week 78, backed by clinical trial data overall.

  • Week 1: Commonly reported: a racing heart or dizziness in the first hours after the first shots, which the label times to within 4 hours
  • Week 2: In its trial, injection-site redness was common in the first month (58% vs 28% on placebo)
  • Week 4: A marker of new bone formation peaked at month 1, 93% above baseline in women (label)
  • Week 52: In its men's trial, spine bone density rose 8.5% at 12 months against 1.2% on placebo
  • Week 78: In its fracture trial, new spine fractures were 0.6% at 18 months against 4.2% on placebo

The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.

Why abaloparatide takes that long

Abaloparatide’s half-life is about 1 hour, so one dose is about 96.9% cleared after 5 hours.

Each dose of abaloparatide clears within 5 hours, so its level doesn’t build up from one day to the next: the weeks on the timeline come from repeated doses, not from the compound piling up in the blood.

Abaloparatide against other healing & recovery compounds

The library holds an onset-and-peak timeline for 12 healing & recovery compounds, abaloparatide among them; none of the others shares its onset of 1 month (bone formation markers).

When healing & recovery compounds start to act and peak, by the library’s timelines
CompoundOnsetPeak effect
BPC-1571–7 days2–4 weeks
TB-5001–2 weeks4–6 weeks
GHK-Cu3–6 weeks8–12 weeks
KPV1–2 weeks4–6 weeks
ThymalinNot established (no controlled timing data)Not established
ThymogenNot established (no controlled timing data)Not established
VilonNot established (no controlled timing data)Not established
LinaclotideWeek 1 (bowel movements)1–12 weeks
ARA-2901–2 weeks (user reports; the trials' main readouts were at day 28)4 weeks, the point the trials measured
CartalaxDays to weeks (commonly reported)Weeks (commonly reported)
Teriparatide1–3 months (bone formation markers, spine BMD)18–24 months (BMD, fracture risk)
Abaloparatide1 month (bone formation markers)12–18 months (BMD, fracture risk)

Questions people ask

How long does abaloparatide take to work?

Abaloparatide’s onset is 1 month (bone formation markers), its peak effect comes at 12–18 months (BMD, fracture risk), and its typical duration is up to 24 months, by the library’s timeline (backed by clinical trial data).

When does abaloparatide reach its peak effect?

By the library’s timeline, abaloparatide’s peak effect comes at 12–18 months (BMD, fracture risk), backed by clinical trial data.

How long is abaloparatide usually run?

The library’s timeline gives abaloparatide’s typical duration as up to 24 months; its cycle note says: The label does not recommend more than 2 years in a lifetime; its fracture trial ran 18 months, followed in the trial by alendronate, which kept the lower fracture risk through 24 more months.

What does the library say about the first days on abaloparatide?

Its first note on abaloparatide, for days 1–14 (weeks 1–2), is “The first shots, sitting down”, resting on randomized trials.

More on abaloparatide

Track it in the app

PepVault for iPhone

Track abaloparatide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo